[Inhibition of neutrophil-derived IL-8 production caused by EM (erythromycin) 201 derivative: modification of the activities by the 5-position desosamine side chain].
Yoshimine
H
H
Oishi
K
K
Nagatake
T
T
Matsushima
K
K
Omura
T
T
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002478:Cells, Cultured; D017291:Clarithromycin / Q000494:pharmacology; D004917:Erythromycin / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D016209:Interleukin-8 / Q000096:biosynthesis*; D009504:Neutrophils / Q000276:immunology*; D013329:Structure-Activity Relationship
D000900:Anti-Bacterial Agents; D016209:Interleukin-8; C093673:8,9-anhydroerythromycin A 6,9-hemiketal; D004917:Erythromycin; D017291:Clarithromycin